Stockscreener 앱 받기
6.09
2.53%
0.15
시장 영업 전:
5.94
-0.15
-2.46%
Chromadex Corp 주식(CDXC)의 최신 뉴스
Barclays PLC Grows Stock Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex Co. (NASDAQ:CDXC) Short Interest Up 6.7% in December - Defense World
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7% - MarketBeat
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - MarketBeat
ChromaDex (NASDAQ:CDXC) Rating Lowered to “Buy” at StockNews.com - Defense World
Jane Street Group LLC Has $167,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
ChromaDex Corp Partners with Persona Nutrition, Expanding Global Partnership with Nestlé Health Science - Marketscreener.com
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
Barclays PLC Purchases 53,472 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Geode Capital Management LLC Raises Holdings in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Downgraded to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.com - MarketBeat
Franklin Resources Inc. Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
State Street Corp Purchases 62,692 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
StockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to “Strong-Buy” - Defense World
Fmr LLC Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Upgraded by StockNews.com - MarketBeat
4 Drug, Biotech Stocks Rising More Than 50% In 2024 With Room To Grow - Barchart
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
ChromaDex appoints Crowe as new auditor By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
MetLife Investment Management LLC Acquires 5,115 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
ChromaDex Named to Inc. 2024 Best in Business List for Health Products Innovation - StockTitan
ChromaDex stock soars to 52-week high, hits $7.87 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $7.87 - Investing.com
Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario - NutraIngredients-usa.com
ChromaDex Co. (NASDAQ:CDXC) CFO Ozan Pamir Buys 2,907 Shares - MarketBeat
Chromadex CFO Pamir Ozan acquires $21,396 in company stock By Investing.com - Investing.com Australia
Chromadex CFO Pamir Ozan acquires $21,396 in company stock - Investing.com India
Insider Buying: Ozan Pamir Acquires Shares of ChromaDex Corp (CD - GuruFocus.com
4.79%
1.72%
자본화:
|
볼륨(24시간):